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Learning objectives
The aims of our poster are:
-to review the MRI technique and protocol in preoperative local staging of rectal cancer
(RC);
-to identify radiological signs that are useful for both the clinician and the surgeon;
-to provide some "tips & tricks" in the radiological evaluation of MR images in RC staging.
Background
Colorectal cancers are the second most frequent tumours in Western countries,
particularly 1/3 of these cancers are localized in the rectum.
Surgery provides a wide range, from the trans-anal resection to multiorgan excision,
remains the best therapeutic choice. However, nowadays, the concept of "mesorectal
excision" is widely accepted among surgeons being supported by a low risk of local
recurrence and a good compliance by patients. Hence, the need for a multidisciplinary
approach, which includes oncologists, surgeons, radiologists and radiotherapists, each
playing a key role in the management of patients with RC.
MRI is a valuable diagnostic tool to carry out a correct preoperative local staging
of the disease and identify patients in need of a chemoradiotherapy (CRT) adjuvant
preoperative or even identify cases where this proves simply a therapeutic overtreatment.
Partly following the numerous scientific guidelines on the MR-staging of the CR and
supported by our personal and validated daily experiences , we aim to offer readers "an
accurate MRI protocol and a radiological template".
Findings and procedure details
Our educational exhibit focuses exclusively on the preoperative evaluation of patients
with CR. However, the MRI protocol described below is applicable both in the first staging
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and in the restaging after adjuvant chemoradiotherapy, but MRI parameters useful in this
latter situation will not be described.
PATIENT PREPARATION
- Although some guidelines do not recommend routine endorectal filling, we recommend
a rectal relaxation through about 60-100 ml of a semiliquid solution containing ultrasound
gel and water, administered by endorectal small cannula.
TIPS & TRICKS: you should advise patients to make two small evacuation enemas
(e.g. through glycerine), respectively the night before and the morning of the MRI
examination;you should not stretch too much the rectal ampulla since it could distort the
morphology of the tumor, smashing it too much on the rectal wall and in rare cases you
will make a compressive effect on mesorectal fat.
- Administration of a spasmolytic agent before image acquisition to reduce bowel motion
artifacts.
TIPS & TRICKS: if you made rectal distension, the spasmolytic agent helps the patient
to maintain continence during MRI examination.
MRI ACQUISITION PROTOCOL:
- Use of high field MRI equipment (at least 1.5 Tesla MR scanner).
- Use phased array surface coil; endorectal coil is not recommended, especially in
patients with stenosing tumor.
- Patient in the supine position.
- Average MR duration: about 30 minutes.
Below the MRI sequences we use in our clinical practice, listed in temporal order; however
are dutiful some premises:
• except for some post-contrastographic imaging and functional studies (DWI
and Dynamic Contrast-Enhanced-DCE), in the morphological evaluation of
the CR by sequences turbo spin echo (TSE) sequences, must not be used
fat suppressed sequences (FAT-SAT);
• slice thickness must be in a range of about 1-4 mm;
MR images acquisition includes sequences acquired before and after contrast medium
injection:
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- PRE-CONTRASTOGRAPHIC SEQUENCES
1. sagittal TSE-T2 weighted: it must be the first acquired sequence: it will constitute a
reference for the following axial and coronal oblique images (see below);
2. axial TSE-T2 weighted: includes the whole pelvis; it shows a panoramic view of the
lower abdomen, including the tumor, extramesorectal and any peritoneal nodes;
3. axial TSE- T1 weighted: same as above but T1 weighted;
4. DWI free-breathing technique and multi b-values (0, 500, 1000 s/mm2) in the axial
plane: quantitative and qualitative evaluation of the tumor.
The hyperintense signal in DWI reflects a high tumor cellularity, intratumoral edema and
any possible intralesional cystic component, which is typical in the mucinous variant of
the CR (Fig.3-left). Moreover, it allows calculating ADC values which are predictive of
a possible neoadjuvant therapy success. Many studies, indeed, have shows that some
CR with low-baseline pretreatment ADC values responded better to chemotherapy or
radiation treatment than tumors with high-pretreatment ADC values. However, there is
not any standardized cut-off value.
TIPS & TRICKS: DWI allows better visualizing even small tumors and identifying, but not
characterizing, peritumoral nodes. The use of high b-values (e.g. 1000 s/mm2) eliminates
the high signal due to the ultrasound gel used for endorectal filling, showing only the
restriction in the signal of the tumor. You should calculate ADC values not just on a small
tumor volume, but on a wide area (ROI) manually drawn that includes the tumor itself,
thus increasing the diagnostic accuracy.
5. oblique axial plane High resolution (HR) TSE T2 weighted: using as reference image
of the TSE-T2 weighted image in the sagittal plane, you have to consider a plane which
is perpendicular to the major axis of the tumor. This is the key sequences of the whole
MRI protocol: since it defines the exact relationship of the tumor to the mesorectal fat
and mesorectal fascia.
TIPS & TRICKS: pretend to have images free from motion artifacts. If tumor is very
wide in length with a curved major axis, you have make a second acquisition using a
perpendicular plane which is slightly modified, and then choose which one best describes
the relationship with the mesorectal fascia.
6. coronal oblique HR TSE T2 weighted: using as reference image sagittal T2 weighted
sequence, you have to create a plane which is parallel to the anal canal. This sequence
is useful in evaluation of sphincter involvement in "low" RC.
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TIPS & TRICKS: these two sequences (axial and coronal oblique) are acquired using a
narrow (16 cm) Field of View (FOV) targeted exclusively to mesorectal region. In axial
and coronal oblique sequences we do not use pre-saturation bands
- POST-CONTRASTOGRAPHIC SEQUENCES
1. DCE-MRI Fat-sat in the axial plane: the perfusion studies allow estimating tumor
neoangiognenesis and predicting response to chemotherapy. Furthermore, together with
DWI sequences, they allow differential diagnosis, in the assessments after adjuvant
therapy, including fibrosis and tumor recurrence.
TIPS & TRICKS:although not being standardized, we consider necessary to perform
perfusion studies to best validate the technique trying to MR- staging not only through
morphological parameters but also with functional ones. Considering that in the protocol
intravenous contrast medium is injected it would be inappropriate if perfusion study were
not performed.
2. axial and sagittal TSE T1 weighted: morphological post-contrastographic evaluation.
3. High-resolution volumetric 3D fat-sat T1 weighted: it provides an excellent post-
contrast enhancement morphological evaluation of the tumor (Fig.2-right and Fig.3-right)
and, in some cases, it is useful in identifying the venous peritumoral spreading.
IMAGES ANALYSIS
Here are parameters that should be evaluated and included in our suggested radiological
template, reporting only "WHAT surgeons, oncologist and radiotherapist WANT"
1. Locate tumor: "Where is the tumor?"
- Measure the distance from the anal margin to lower border of the tumor:
• < 5cm: lower III of the rectum (low rectal);
• between 5-10cm: medium III of the rectum (mid rectal);
• > 10 cm: upper III of the rectum (high rectal);
TIPS & TRICKS: tumors of the upper rectum easily spread in the peritoneum; this latter
covers only the anterior wall of the rectum. The tumors of the low rectum tend to recur
more.
- Craniocaudal extension of the tumor (measured in centimetres).
- Distance between anal verge and upper border of the tumor.
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2. Depth of invasion through the layers of the intestinal wall and in the surrounding
Mesorectal fat: " What is the tumor spread?"
-T staging: the process of T-Staging is shown in the Table 1 and Fig.1.
MRI helps to distinguishing the different layers of the bowel: in T2 weighted images, the
submucosa has an high signal intensity, the muscolaris has a low signal intensity, while
the perirectal fat has an high signal intensity and contains signal void vessels.
TIPS & TRICKS: Do this assessment just on HR T2 weighted sequences in the
axial oblique plane (Fig. 2-left). T1 and T2 tumors can not be distinguished through
MRI, endoanal ultrasound must be used in these cases. You will often find some
difficulties in tumors with minimal mesorectal spread (T3a, T3b), because around
the rectal wall there can be present a desmoplastic stromal reaction, which can be
misinterpreted as tumor tissue. Hence, we advise to use these criteria: appearance with
"spiculated" striae represents a desmoplastic fibrotic reaction, while the presence of
"broad based" or nodular tissue permeating into the mesorectal fat and in continuity with
the intramural portion of the tumor is indicative of neoplastic spread. Remember that
the distinction between T2 and T3 with mesorectal invasion less than 5 mm (T3a and
T3b) may be irrelevant, as these types of cancer may not benefit from some adjuvant
chemoradiotherapy.
- Growth pattern: annular, polypoid , ulcerated , mixed.
- Sfinterial staging : in cases of " low" rectal cancer it is useful to carry out a tumor staging
considering the sphincter structures (see Table 2 and Fig.4). Use the coronal oblique
plane HR T2 weighted sequences.
3. Involvement of mesorectal fascia: "What is the status of Mesorectal Fascia?"
- Evidence of direct infiltration of the mesorectal fascia by the tumor or nodes: yes or no
- Circumferential Resection Margin (CRM) status: shortest distance from the tumor in the
mesorectal fat to the mesorectal fascia (measured in millimetres):
• > 1 mm: CRM negative
• < 1 mm: CRM positive
TIPS & TRICKS: the presence of a node distant less than 1 mm from the mesorectal
fascia is predictive of infiltration (CRM positive; see later).
4. NODAL STATUS: " What is the nodal involvment?"
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- N-stage: number of probably metastatic nodes within the mesorectal fat:
• N0: no nodes
• N1: 1-3 nodes
• N2: >4 nodes
Criteria of malignancy: size> 8 mm; round shape with a short axis diameter > 5 mm;
irregularity of the surrounding capsule; irregular and spiculates borders; inhomogeneous
intensity signal MRI (likely contain areas of necrosis or mucin); the presence of intranodal
fat is not a typical feature of mesorectal nodes. Post-contrastographic enhancement is
present in both hyperplastic and metastatic nodes.
- Node at <1 mm of distance from mesorectal fascia: CRM+
- Extramesorectal nodes: located in the pelvis (iliac, obturator, etc)
TIPS & TRICKS: The nodal involvement is defined with certainty only through
histopathology; MRI alone is not sufficient due to the presence (not uncommon) of
micrometastases. Use caution in their assessment; remember that the nodal spread is
one of the most important risk factors both for local and distant recurrence. The DWI
evaluation does not increase the specificity. Both malignant and benign nodes shows
high signal on DWI images. Use however this sequence to facilitate their detection
(especially for small nodes). The ADC of metastatic nodes is usually lower, but it is not
yet estabilished a reference cut-off. Currently you can not use it as a diagnostic criterion.
5. Negative prognostic factors associated: "There are more poor prognostic factors?
- Extramural vascular Invasion (EMVI): the presence of venous vascular spread is
indicative of probable relapse and/or high malignancy. Diagnostic criteria EMVI: proximity
between tumor and vascular structures; rounded edges of the vessels, swollen and
widen appearance (presence of intraluminal tumor tissue, neoplastic thrombosis) and
inhomogeneous signal intensity (reduced artefact flow void)
TIPS & TRICKS: do not confuse EMVI with peritumoral desmoplastic reaction (spiculated
and thin appearance)
- Presence of intratumoral mucin pool: hyperintense foci on T2w sequences, indicative
of mucin pool.
TIPS & TRICKS: The mucinous variant of CR is correlated with increased local
recurrence, nodal and peritoneal spread. Intratumoral necrosis or abscesses can mimic
mucin pool. Medium signal intensity in FatSat T2w images and intravenous administration
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of gadolinium can help: in some cases, mucin shows a rise of intensity signal in post-
contrastographic sequences.
- Pelvic secondary nodulations: peritoneal metastatic nodules, with spiculated and
irregular margins that show inhomogeneous post-contrastographic enhancement (tumor
like).
- Dynamic perfusional evaluation:
• Wash-in and Wash-out curves: in our experience the neoplastic tissue
(compared to healthy rectal wall) has a significant and rapid wash-in with
moderate plateau phase and/or mild wash-out.
• K-trans: the presence of high values of K-trans in the context of the tumor
tissue, compared to normal rectal wall, is indicative of neoplasia.
TIPS & TRICKS: although still under study, perfusion imaging is used as tool for
assessing angiogenesis and thus the possibility of CRT success. Rectal tumors with
higher permeability at presentation appear to respond better to CRT than those of
lower permeability. Ongoing studies are evaluating its usefulness in the response
to neoadjuvant treatment (in combination with assessment DWI) with the ability to
discriminate the residual tumor from fibrosis.
Images for this section:
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Table 1: T-Staging
Table 2: Sfinterial Staging (for "low" rectal cancer
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Fig. 1: T-Staging
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Fig. 2: MRI study shows mid-rectal cancer, mesorectal spread(T3), inhomogeneous
contrast enhancement and moderate vascular spreading.
Fig. 3: MRI study shows mid-Low rectal cancer with inhomogeneous contrast
enhancement, vascular spreading, high restriction in DWI sequence and presence of
metastatic lymph node close to mesorectal fascia.
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Fig. 4: Sfinterial Staging
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Conclusion
Local staging of rectal cancer through MRI plays a key role in patient's therapeutic
management, reducing the risk for local recurrence or distal spread and helps to
preoperatively identify valuable prognostic information. MRI report must be focused to
provide clear, detailed and above all "necessary" data to the multi-disciplinary team
(oncologist, radiotherapist, surgeons) involved in the management of the patient. Each
of them would love to get from radiologist comprehensive and exhaustive local staging
in order to draw up a proper therapeutic planning of each patient with RC.
Personal information
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